Latest Breaking News On - லிங்கன் பார்மா - Page 1 : comparemela.com

Lincoln Pharma earmarks Rs 30 Cr for facility expansion in Mehsana

Lincoln Pharma earmarks Rs 30 Cr for facility expansion in Mehsana
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

United statesLincoln pharmaMahendra patelLincoln pharmaceuticalsCefalexin oral suspensionClavulanate tabletsCefixime capsulesCefuroxime axetil tabletsLatin americaSoutheast asiaஒன்றுபட்டது மாநிலங்களில்லிங்கன் பார்மாமகேந்திரா படேல்லிங்கன் மருந்துகள்லத்தீன் அமெரிக்காதென்கிழக்கு ஆசியா

Nifty, Sensex may rise if global selloff stops - Tuesday closing report

Nifty, Sensex may rise if global selloff stops - Tuesday closing report
moneylife.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneylife.in Daily Mail and Mail on Sunday newspapers.

United statesAndhra pradeshNew delhiLincoln pharmaGlenmark pharmaMwp al husainiyahDelhi televisionKp energySoftsol resources incTata motorsAdani groupCompetition commission of indiaGodrej industriesMylan pharmaceuticals incGangavaram portCompetition commission

Lincoln Pharma Q4 standalone net up 30% - The Hindu BusinessLine

Lincoln Pharma Q4 standalone net up 30% May 25, 2021 Net revenues from operations rises to ₹78 crore Lincoln Pharmaceuticals Limited on Tuesday posted standalone net profit of ₹12 crore for the fourth quarter ended March 31, , against ₹Rs 9 crore in the corresponding quarter a year ago, a 30 per cent jump. Standalone net revenues from operations for the quarter stood at ₹78 crore (₹75 crore). Standalone EBITDA was at ₹17 crore, up 28 per cent compared ₹13 crore in the corresponding period last year. For the financial year ended March 2021, the company s net profit stood at ₹60 crore (₹50 crore) a jump of 22 per cent year-on-year. Standalone net revenues from operations for the fiscal stood at ₹413 crore (₹376 crore).

Lincoln pharmaMahendra patelLincoln pharmaceuticalsLincoln pharmaceuticals limited onLincoln pharmaceuticals limitedManaging directorலிங்கன் பார்மாமகேந்திரா படேல்லிங்கன் மருந்துகள்லிங்கன் மருந்துகள் வரையறுக்கப்பட்டவை ஆன்லிங்கன் மருந்துகள் வரையறுக்கப்பட்டவைநிர்வகித்தல் இயக்குனர்குயிவ் 4

Lincoln Pharma Q3 net up 23% to Rs 13 cr on strong domestic, global biz

On the back of strong domestic and international business, Lincoln Pharmaceuticals Limited posted a 23.44 per cent rise in its consolidated net profit for the third quarter ended December 31, 2020 at Rs 13.48 crore, from Rs 10.92 crore in the same quarter last year. The drug maker s consolidated total revenue also grew by 13.70 per cent to Rs 115.47 crore in Q3 of FY 2020-21, from Rs 101.55 crore in Q3 of FY 2019-20. According to Lincoln Pharma s managing director Mahendra Patel, the growth in revenue and profit came on the back of strong domestic and international business. The company posted a 15.56 per cent growth in sales and a four per cent growth in exports. Moreover, the company s exports grew by 17.56 per cent year-on-year (YoY) basis for the nine months ended December 31, 2020 at Rs 212.47 crore.

Lincoln pharmaMahendra patelLincoln pharmaceuticalsLincoln pharmaceuticals limitedSoutheast asianலிங்கன் பார்மாமகேந்திரா படேல்லிங்கன் மருந்துகள்லிங்கன் மருந்துகள் வரையறுக்கப்பட்டவைதென்கிழக்கு ஆசிய